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Abstract  
Background: Hyperbilirubinemia is the most common reason for admission during the neonatal 
period and may develop serious complications. Thrombocytopenia is defined as platelet count 
<150,000/mm
3
 and has not been conclusively reported as a complication of hyperbilirubinemia in 
any of the standard paediatric textbooks. The aim of this study was to find the incidence of 
thrombocytopenia in neonates with idiopathic jaundice and the relationship between 
hyperbilirubinaemia and platelet count. 
Methods: This was a descriptive-analytic study accomplished on 878 newborns. After a detailed 
history, clinical examination and baseline investigations,185 babies with idiopathic 
hyperbilirubinemia were tested for platelet counts and then categorized in two groups namely group 
A (n=65) and group B (n=120) showing the presence and absence of thrombocytopenia, 
respectively. Newborns data were recorded and Statistical analysis was carried out, using SPSS 
11.5. 
Results: The incidence of thrombocytopenia was seen in 65 (12%) newborns admitted due to 
jaundice. The mean serum bilirubin in group A and B was defined as 19.7 (± 6) and 20.4 (± 5), 
respectively (P = 0.362).There was no significant difference in Laboratory variables like TSH, T4, 
coombs test, reticulocite count, serum sodium and hematocrit values between two groups. 
Conclusion: This study determines higher rate of thrombocytopenia among idiopathic 
hyperbilirubinemic neonates (36%) and helps the practitioner to be aware of this association and 
avoid unnecessary investigations.We did not find a significant correlation between serum bilirubin 
values and thrombocytopenia. 
 
 
 
 
 
Introduction 
Hyperbilirubinemia is a common and in most 
cases benign problem in first mouth of life which is 
often physiologic and intervention is not usually 
necessary.  
Hyperbilirubinemia may increase in 8-11% of 
newborns to higher than 95% of percentile and 
evaluation and management might be required [1]. 
Bilirubin is the final product of hem catabolism and its 
serum level is determined by combination of bile 
production, hepatic conjugation and enterohepatic 
circulation [2]. Although mild increase in serum 
bilirubin has some advantageous affects but potential 
central nerves system toxicity may occur due to 
indirect bilirubin increase [3]. Jaundice is the most 
common reason for admission during the neonatal 
period. Multiple variables (maternal, infantile, during 
labor and environmental factors) affect the course and 
severity of jaundice. Hyperbilirubinemia may develop 
serious complications like kernicterus and lifelong 
disability. Kernicterus causes 10 percent of death and 
70 percent of disorders associated with 
hyperbilirubinemia. Asian ethnicity is more affected to 
kernicterus [4]. 
Thrombocytopenia is a common problem in 
the newborn. Previous studies report a prevalence of 
thrombocytopenia of 1–5% of all newborns and may 
develops in 18% to 35% of NICU patients [5, 6]. 
Thrombocytopenia is defined as platelet count 
<150,000/mm
3
 regardless of the gestational age. 
Thrombocytopenia as a side effect of phototherapy, 
which has not been described in the standard 
textbooks, although many authors did try to look into 
this particular side effect. Maurer et al and Pishwa et 
al observed in their studies that neonates exposed to 
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phototherapy had decreased platelet counts and 
increased platelet turnover [7, 8].  
This study was done with an aim to find the 
incidence and cause of thrombocytopenia in neonates 
with jaundice and the relationship between 
hyperbilirubinaemia and platelet count. 
 
 
Subjects and Methods 
This was a descriptive-analytic study 
accomplished on 878 newborns aged between 3 to 30 
days with Clinical jaundice admitted to NICU, pediatric 
emergency room and clinic of neonatology during 
March 2008 to April 2012 at Ghaem Hospital in 
Mashhad, Iran. After a detailed history, clinical 
examination and baseline investigations, 185 babies 
with idiopathic hyperbilirubinemia were found eligible 
for the study. Neonates, who were preterm or low birth 
weight, had noncompliant parents, infants who were 
symptomatic (respiratory, distress syndrome, fever, 
congenital anomaly, renal insufficiencyand etc), direct 
hyperbilirubinaemia, sepsis, anti-platelet drugs given 
to baby or mother, haemangioma were excluded. 
Platelet counts were performed at admission. 
Neonates who were includedin this study then 
categorized in two groups namely group A (n=65) and 
group B (n=120) showing the presence and absence 
of thrombocytopenia (platelet count of less than 
150,000/mm
3
), respectively (Figure1). 
 
Figure 1: Chart of study. 
 
Neonatal variables like sex, birth weight, 
gestational age, age at admission, duration of 
hospitalization, laboratory tests (indirect and direct 
bilirubin, coombs test, hematocrit, retic count, urea, 
creatinin, blood group,  and in some cases and thyroid 
test) compared between two groups. Maternal data 
like age, type of delivery, duration of mother 
hospitalization after delivery, number of parturition, 
blood group and Rh were recorded and compared. 
Statistical analysis was carried out using SPSS 11.5. 
The Student T-test, Mann-Whitney and Chi-square 
test were performed on quantitative and qualitative 
variables. P-value less than 0.05, was considered 
statistically significant. 
The ethic committee of Mashhad University of 
Medical Science approved this study and all parents 
signed informed consent. 
 
 
Results 
A total of 185 neonates with idiopathic 
jaundice were enrolled in current study. We found 
65babies with thrombocytopenia (group A) and 120 
babies with normal platelet count (group B). 
The incidence of thrombocytopenia was seen 
in 103 (12%) newborns admitted due to jaundice. In 
our study, the average initial platelet count in 
thrombocytopenia group was109 ± 31×10
3
 while the 
average initial platelet count in non-thrombocytopenia 
group was 292 ± 92×10
3
 /mm
3
.  
Majority of neonates (86.4%) had mild 
thrombocytopenia (100-150×10
3
). Moderate and 
severe thrombocytopenia was seen in (14.6%) cases, 
respectively. 
The current study shows idiopathic 
thrombocytopenia was the most common cause of 
thrombocytopenia among newborns (63%) and other 
disorders that decreased platelet count was defined 
such as ABO incompatibility, polycythemia, UTI, 
sepsis, infant of diabetic mother (IDM) and down 
syndrome and etc (Figure 2). 
 
Figure 2: Probable causes of thrombocytopenia among 
hyperbilirubinemic newborns. 
 
Basic and clinical findings including sex, birth 
weight, mode of delivery, time of jaundice 
appearance, parturition number, and age of admission 
and hospitalization period in both groups were 
recorded and compared (Table1). We did not find 
significant differences between two groups (p>0.05). 
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Table 1: Basic and clinical findings of newborns in two groups. 
Group 
ClinicalFindings 
A 
(thrombocytopenia) 
B 
(normal 
platelet) 
Chi-
Sqaure 
Value 
P-
Value 
Sex (m/f) 39/26 62/58 1.285 0.257 
Mode of delivery 
(NVD/CS) 
34/31 44/35 0.047 0.829 
Multiparity/Primiparity 26/24 28/37 6.228 0.285 
     
Group 
ClinicalFindings 
A 
(thrombocytopenia) 
B 
(normal 
platelet) 
t-test 
Value 
P-
Value 
Mean Birth weight ± 
STD (gr) 
2.85 ± 765 
3070 ± 
605 
-1.745 0.083 
Jaundice appearance 
(day) 
3 3.6 0.501 0.133 
Hospitalization period 
(day) 
2.6 3.4 -1.068 0.065 
 
 
The mean serum bilirubin in group A and B 
was defined as 19.7 (± 6) and 20.4 (± 5), respectively 
(P=0.362, Table 2). There was no significant 
difference in Laboratory variables like TSH, T4, 
coombs test, reticulocite count, serum sodium and 
hematocrit values between two groups (P>0.05, Table 
3). 
 
Table 2: Bilirubin values among two groups.  
Group 
 
A 
(thrombocyto
penia) 
B 
(normal 
platelet) 
t-test 
Value 
P-Value 
Mean Serum bilirubin 
± std.(mg/dl) 
19.7±6 20.4±5 -0.913 0.362 
 
Although hematocrit values were lower 
among thrombocytopenic group but the differences 
was not significant (P>0.05, Figure 3). 
 
Table 3: Laboratory values among two groups. 
Group 
laboratory findings 
A 
(thrombocytopenia) 
B 
(normal platelet) 
P-Value 
TSH 4.06 6.36 0.202 
T4 11 9.7 0.35 
Retic count (%) 1.28 0.93 0.183 
Hematocrit 45.7 47.3 0.145 
Sodium (mg/dl) 142 140 0.296 
 
 
Discussion 
In our study, the incidence of 
thrombocytopenia among newborns admitted with 
hyperbilirubinemia was 12%. The incidence of 
thrombocytopenia varies by population. In the well 
newborn population, the incidence is less than 5%. In 
the neonatal intensive care unit (NICU), however, the 
incidence of thrombocytopenia is much higher and 
may develop in 18% to 35% of NICU patients. Lower 
prevalence rate reported in this study may be 
explained by admission of some newborns in clinic 
and neonatal ward which was apart from NICU.   
We found higher rate of thrombocytopenia 
among male sex and multiparous mother, however 
these associations were not statistically significant. 
Our results were in agreement with Maj et al study [9]. 
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Figure 3: Mean values of hematocrit among two groups. 
 
None of the neonates with thrombocytopenia 
(group A), in our as well as the other study, had 
clinical manifestations of bleeding. Our explanation for 
the same could be the fact that thrombocytopenia was 
transient and rarely found to be severe in babies with 
idiopathic hyperbilirubinemia. This study establishes 
higher rate of thrombocytopenia among idiopathic 
hyperbilirubinemic neonates (36%) that might be 
related to incomplete investigation to find out causes 
of hyperbilirubinemia, so as with improvement in 
diagnostic tools and complete evaluation of jaundice 
in future studies, this rate would be declined.  
Duration of hospitalization between both 
groups did not show any significant differences 
(P>0.05) and suggest thrombocytopenia was not 
related to any significant underline disease. 
The mean serum bilirubin in   group A and B 
did not show any significant differences (P>0.05). With 
respect to the bivariate correlations, we did not find a 
significant correlation between serum bilirubin values 
and thrombocytopenia. We believe larger multicenter 
trials preferably with Measurement of plasma Tpo may 
provide valuable diagnostic information in infants with 
thrombocytopenia in the future. 
To conclude, this study establishes higher 
rate of thrombocytopenia among idiopathic 
hyperbilirubinaemic neonates (36%) and helps the 
practitioner to be aware of this association and avoid 
unnecessary investigations, as thrombocytopenia was 
mild and transient. Though the incidence of 
thrombocytopenia is substantial, yet we did not find a 
significant correlation between serum bilirubin values 
and thrombocytopenia. 
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